Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on June 16, 2005

Arteriosclerosis, Thrombosis, and Vascular Biology. 2005
Published online before print June 16, 2005, doi: 10.1161/01.ATV.0000174126.28201.61
A more recent version of this article appeared on August 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/8/1577    most recent
01.ATV.0000174126.28201.61v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zheng, H.
Right arrow Articles by Katz, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, H.
Right arrow Articles by Katz, S. D.

Submitted on March 16, 2005
Accepted on June 1, 2005

Iron Stores and Vascular Function in Voluntary Blood Donors

Haoyi Zheng ; Ritchard Cable ; Bryan Spencer ; Nancy Votto ; and Stuart D. Katz *

From the Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Conn; and The American Red Cross Blood Services, Farmington, Conn and Dedham, Mass.

* To whom correspondence should be addressed. E-mail: stuart.katz{at}yale.edu.

Background--Iron is a pro-oxidant cofactor that may be linked to atherosclerosis progression. Reduction of body iron stores secondary to blood donation has been hypothesized to reduce coronary risk, but retrospective studies have yielded inconsistent findings. We sought to assess the effects of blood donation frequency on body iron stores and physiological and biochemical biomarkers of vascular function associated with atherosclerosis progression.

Methods and Results--Forty high-frequency voluntary blood donors (≥8 donations in past 2 years) and 42 low-frequency blood donors (1 to 2 donations in past 2 years) aged 50 to 75 years were randomly selected from American Red Cross of Connecticut blood donor records. Flow-mediated dilation in the brachial artery, serum markers of iron stores, vascular inflammation and oxidative stress, and cardiac risk factors were assessed in all subjects. Serum ferritin was significantly decreased in high-frequency blood donors when compared with low-frequency blood donors (median values 17 versus 52 ng/mL; P<0.001), but hematocrit did not differ between groups. Flow-mediated dilation in the brachial artery was significantly greater in high-frequency donors when compared with low-frequency donors in univariate analysis (5.5±2.6% versus 3.8±1.6%; P=0.0003) and in multivariate analysis adjusting for cardiac risk factors and other potential confounders. Serum biomarkers of vascular inflammation did not differ between groups but 3-nitrotyrosine, a marker of oxidative stress, was decreased in high-frequency donors when compared with low-frequency donors.

Conclusions--High-frequency blood donors had evidence of decreased body iron stores, decreased oxidative stress, and enhanced vascular function when compared with low-frequency donors. These findings support a potential link between blood donation and reduced cardiovascular risk that warrants further investigation in prospective outcome studies.


Key words: ferritin • nitric oxide • oxidative stress • vascular endothelium • vasodilation




This article has been cited by other articles:


Home page
Diabetes CareHome page
H. Zheng, M. Patel, R. Cable, L. Young, and S. D. Katz
Insulin Sensitivity, Vascular Function, and Iron Stores in Voluntary Blood Donors
Diabetes Care, October 1, 2007; 30(10): 2685 - 2689.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. l. Sullivan
Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability
Experimental Biology and Medicine, September 1, 2007; 232(8): 1014 - 1020.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. L. Sullivan and S. D. Katz
Iron Reduction and Cardiovascular Outcomes
JAMA, May 16, 2007; 297(19): 2075 - 2075.
[Full Text] [PDF]


Home page
JAMAHome page
L. R. Zacharski, B. K. Chow, P. S. Howes, G. Shamayeva, J. A. Baron, R. L. Dalman, D. J. Malenka, C. K. Ozaki, and P. W. Lavori
Reduction of Iron Stores and Cardiovascular Outcomes in Patients With Peripheral Arterial Disease: A Randomized Controlled Trial
JAMA, February 14, 2007; 297(6): 603 - 610.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
L. M Yunker, J. S Parboosingh, H. E Conradson, P. Faris, P. J Bridge, J. Buithieu, L. M Title, F. Charbonneau, S. Verma, E. M Lonn, et al.
The effect of iron status on vascular health
Vascular Medicine, May 1, 2006; 11(2): 85 - 91.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. E. Ferrara and W. R. Taylor
Iron Chelation and Vascular Function: In Search of the Mechanisms
Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2235 - 2237.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. L. Sullivan
Stored Iron and Vascular Reactivity
Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1532 - 1535.
[Full Text] [PDF]